Development of novel disruptive affinity purification technology
You will have a key role in a cross disciplinary product development team and will be responsible for designing and conducting various development activities...
In CHRETO you will be responsible for scaling up our proprietary affinity purification technology for antibodies, from lab to pilot and later to commercial scale. You will have a key role in a cross disciplinary product development team and will be responsible for designing and conducting various development activities including reaction kinetic studies and downstream lab investigation and production trials.
Supervision of contract manufacturing and research organizations will also be part of the daily routines. The focus is to secure the commercialisation of our first product in the end of 2018. Following the commercialisation the forward focus will be on developing affinity purification processes for other large biomolecules to expand the technology to a platform technology.
CHRETO is searching for a experienced protein scientist, preferebly at PhD level, to lead scale up and further development of our propriertery single-use purification technology. You should be able to provide downstream solutions and technical support to our key biopharmaceutical collaborations partners in Europe and US. You have a holistic view of manufacturing requirements for commercial biopharmacuetical products with documented and profound knowledge in downstream process development, scale up and technology transfer. Furthermore, you have insight into critical parameters affecting manufacturing cost, QC and regulatory requirement. Experience from the biopharmaceutical industry will be considered an advantage.
The pivotal role defining the scientific professionalism is based on being:
- Natural to knowledge sharing as well as working independently and project oriented.
- Entrepreneurship with a high drive and a sense of urgency.
- Strong communication and international co-operation skills.
- Fluent in written and spoken English.
You will be a part of a high performing scientific team with a spirit to radically change the downstream purification process in the biopharmaceutical industry. You will be based in Værløse and have international collaboration partners based in Scandinavia, Europe and US.
About the CHRETO Technology
CHRETO is developing a cost effective and flexible, disruptive single-use platform technology for affinity purification to be used in the biopharmaceutical industry.
Our vision is that the CHRETO technology™ will radically improve the process efficiency of downstream processing of large biomolecules. We believe that CHRETO Technology™ will bring a true revolution to bio-manufacturing, which has been sought by the industry for decades.
Our goals are to have the first product on market in 2018 and to position CHRETO as the preferred purification technology for monoclonal antibodies (mAb) and intravenous immunoglobulin (IVIG) going forward.
Please contact Sr. HR Partner Conny Ditlevsen, Ditlevsen Human Development, at tel: +45 2267 1000/email: cd@L2C.dk.
Workplace: CHRETO Aps, Lejrvej 17, DK-3500 Vaerloese, Denmark.
Application deadline: As soon as possible and at the latest 11. May 2018.
Apply for the position: To apply for the position, click on the link "Ansøg" on this page and follow the instructions.
Please write in your application that you've seen the job at Jobfinder